QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=5A8DCC19A6C720B7FDF6079E39A4F1FF;jsessionid=29231F5642B615291746BB7670ACC43B;jsessionid=F9236F10524169D80433DBDCA0099910;jsessionid=AA05ADBFA58661636996066C8A33B207;jsessionid=6581200B42C627D841A63CE004A6467D;jsessionid=4ABA35CD64D2F5F42877B3D39446B405 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
3. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
4. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
5. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=5A8DCC19A6C720B7FDF6079E39A4F1FF;jsessionid=29231F5642B615291746BB7670ACC43B;jsessionid=F9236F10524169D80433DBDCA0099910;jsessionid=AA05ADBFA58661636996066C8A33B207;jsessionid=6581200B42C627D841A63CE004A6467D;jsessionid=4ABA35CD64D2F5F42877B3D39446B405